Commissioner upholds refund claims for pharmaceutical products, clarifies refund rules and applicability of Circulars

The Commissioner rejected all four appeals challenging refund claims under GST for pharmaceutical products, upholding the Sanctioning Authority's decisions. The judgment affirmed the calculation method of refunds under Rule 89(5) of CGST Rules, clarified the limited applicability of Circular No. 59/33/2018-GST to post-issuance claims, and noted the unavailability of cross-utilization of input tax credit at the relevant time. It emphasized the Sanctioning Authority's correct interpretation and application of CGST law provisions in approving refund claims, ultimately dismissing the appeals.

---

---

Issues:
Refund claims under GST for pharmaceutical products; Computation of refund under Rule 89(5) of CGST Rules; Applicability of Circular No. 59/33/2018-GST; Cross-utilization of input tax credit; Interpretation of Circulars by Sanctioning Authority.

Analysis:

Issue 1: Refund claims under GST for pharmaceutical products
The Appellant, a pharmaceutical manufacturer, filed four refund claims for unutilized input tax credit due to an inverted duty structure. The Sanctioning Authority rejected the claims partly based on the definition of Net ITC and turnover calculation, leading to the appeals challenging the orders.

Issue 2: Computation of refund under Rule 89(5) of CGST Rules
The main issue revolved around whether the refund computation should be done separately for each tax head or as a consolidated ITC. The Circular No. 59/33/2018-GST clarified the refund process, but the Appellants argued for a consolidated approach. The judgment analyzed the relevant provisions and upheld the Sanctioning Authority's decision on the calculation method.

Issue 3: Applicability of Circular No. 59/33/2018-GST
The Appellants sought the benefit of Circular No. 59/33/2018-GST for their refund claims, emphasizing system validations in calculating refund amounts. However, the judgment highlighted that the circular applied only to post-issuance refund applications, not retroactively. The Sanctioning Authority's decision was upheld based on the timing of claim adjudication.

Issue 4: Cross-utilization of input tax credit
The Appellants argued for cross-utilization of input tax credit as per the Circular dated 4-9-2018, but the judgment clarified that this facility was not available on the portal at the time. The retrospective nature of the circular limited its application to pending refund claims, not those already adjudicated, supporting the Sanctioning Authority's decisions.

Issue 5: Interpretation of Circulars by Sanctioning Authority
The judgment emphasized that circulars serve to clarify procedures under the law for uniform implementation. While the Appellants cited case laws to support the binding nature of circulars, the judgment concluded that the Sanctioning Authority correctly applied the provisions of the CGST law in sanctioning the refund claims, upholding their decisions.

In conclusion, the Commissioner rejected all four appeals and upheld the impugned sanctioned orders, emphasizing the correct application of CGST law provisions by the Sanctioning Authority in calculating and approving the refund claims.

---